Intermittent claudication: prevalence and risk factors.
W G Hughson
J I Mann
A Garrod
Abstract
Risk factors for intermittent claudication (IC) were studied in 54 patients--that is, all patients with IC on the lists of two general practices--and 108 controls. Smoking was the factor most strongly associated with the development of IC, but systolic and diastolic blood pressures and concentrations of triglyceride, urate, and fibrinogen were all significantly higher among the patients with IC than the controls. The presence of more than one factor appeared to be associated with a multiplicative increase in risk. Cholesterol, an important risk factor for ischaemic heart disease, was not associated with an increased risk of IC. IC was present in about 2% of the men and 1% of the women, who were aged 45-69 years. These findings suggest that IC, a common and disabling manifestation of atheroslcerosis, may be largely preventable.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cramp D. G., Robertson G. The fluorometric assay of triglyceride by a semiautomated method. Anal Biochem. 1968 Oct 24;25(1):246–251. doi: 10.1016/0003-2697(68)90097-3. [DOI] [PubMed] [Google Scholar]
- Dintenfass L., Julian D. G., Miller G. E. Viscosity of blood in normal subjects and in patients suffering from coronary occlusion and arterial thrombosis. An in vitro study in the absence of anticoagulants, by means of a rotational cone-in-cone trolley viscometer. Am Heart J. 1966 May;71(5):587–600. doi: 10.1016/0002-8703(66)90308-5. [DOI] [PubMed] [Google Scholar]
- Dormandy J. A., Hoare E., Colley J., Arrowsmith D. E., Dormandy T. L. Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. Br Med J. 1973 Dec 8;4(5892):576–581. doi: 10.1136/bmj.4.5892.576. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gordon T., Kannel W. B. Predisposition to atherosclerosis in the head, heart, and legs. The Framingham study. JAMA. 1972 Aug 14;221(7):661–666. [PubMed] [Google Scholar]
- Gordon T., Kannel W. B. Predisposition to atherosclerosis in the head, heart, and legs. The Framingham study. JAMA. 1972 Aug 14;221(7):661–666. [PubMed] [Google Scholar]
- Greenhalgh R. M., Rosengarten D. S., Mervart I., Lewis B., Calnan J. S., Martin P. Serum lipids and lipoproteins in peripheral vascular disease. Lancet. 1971 Oct 30;2(7731):947–950. doi: 10.1016/s0140-6736(71)90269-8. [DOI] [PubMed] [Google Scholar]
- JUERGENS J. L., BARKER N. W., HINES E. A., Jr Arteriosclerosis obliterans: review of 520 cases with special reference to pathogenic and prognostic factors. Circulation. 1960 Feb;21:188–195. doi: 10.1161/01.cir.21.2.188. [DOI] [PubMed] [Google Scholar]
- Keen H., Rose G., Pyke D. A., Boyns D., Chlouverakis C. Blood-sugar and arterial disease. Lancet. 1965 Sep 11;2(7411):505–508. doi: 10.1016/s0140-6736(65)91470-4. [DOI] [PubMed] [Google Scholar]
- Lewis B., Chait A., Oakley C. M., Wootton I. D., Krikler D. M., Onitiri A., Sigurdsson G., February A. Serum lipoprotein abnormalities in patients with ischaemic heart disease: comparisons with a control population. Br Med J. 1974 Aug 24;3(5929):489–493. doi: 10.1136/bmj.3.5929.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MANTEL N., HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–748. [PubMed] [Google Scholar]
- Newland H. Hyperuricemia in coronary, cerebral and peripheral arterial disease: an explanation. Med Hypotheses. 1975 Jul-Aug;1(4):152–155. doi: 10.1016/0306-9877(75)90011-0. [DOI] [PubMed] [Google Scholar]
- Pike M. C., Morrow R. H. Statistical analysis of patient-control studies in epidemiology. Factor under investigation an all-or-none variable. Br J Prev Soc Med. 1970 Feb;24(1):42–44. doi: 10.1136/jech.24.1.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- RATNOFF O. D., MENZIE C. A new method for the determination of fibrinogen in small samples of plasma. J Lab Clin Med. 1951 Feb;37(2):316–320. [PubMed] [Google Scholar]
- Winocour P. D., Turner M. R., Taylor T. G., Munday K. A. Gout and cardiovascular disease. Lancet. 1977 Apr 30;1(8018):959–960. doi: 10.1016/s0140-6736(77)92264-4. [DOI] [PubMed] [Google Scholar]